INFUSION PROVIDERS ALLIANCE for INFUSION PROVIDERS ALLIANCE
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Implementation of provisions included in Subtitle B of PL. 117-169 - The Inflation Reduction Act of 2022. HR 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act. Issues related to White Bagging. Issues related to virtual supervision of infusion drugs. Issues related to down coding of certain complex Part B drugs by regional Medicare Administrative Contractors (MACs). Extension of certain telehealth flexibilities included in H.R. l0545 - the American Relief Act, 2025 Issues related to MACRA Reform including HR 2474 - Strengthening Medicare for Patients and Providers Act. Issues related to physician payment included in H.R. l 0445 - Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act Access to Alzheimer's Disease therapies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRAD TRAVERSE New | Former Senior Advisor, Office of the HHS Assistant Secretary of Public Affairs |
Health Issues HCR
Issues related to the Change Healthcare cyber-attack. Support for site neutrality policies including in H.R. 3561 - the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act of 2023 or the PATIENT Act of 2023. Advocating for access to biosimilars. S. 652/HR 2630, Safe Step Act. S. 1375/HR 830, HELP Copays Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRAD TRAVERSE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.